Skip to content

Mineralys Therapeutics, Inc. MLYS Unrecognized tax benefits

Unrecognized tax benefits at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
Medtronic logo
MedtronicMDT
Boston Scientific logo
Boston ScientificBSX
ITG
Integer HoldingsITGR

Other financials

Income statement

See full
Operating income-$45.3M-2.0%
Net income-$39.3M+6.8%
EPS (diluted)-$0.47+40.5%

Balance sheet

See full
Cash & equivalents$1.2M-14.6%
Total equity$638.1M+86.8%
Total assets$652.9M+83.9%

Cash flow

See full
Operating cash flow-$39.5M+13.2%
CapEx$15.0K
Free cash flow-$37.9M+43.3%

Valuation

See full
Market cap$2.26B+124%

Returns & leverage

See full
Return on equity-31%-9.6pp
Current ratio44.3×+17.8×

Where this comes from

Reported directly by Mineralys Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefits.

The official record: Mineralys Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mineralys Therapeutics, Inc.'s unrecognized tax benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mineralys Therapeutics, Inc.'s unrecognized tax benefits?
Mineralys Therapeutics, Inc. (MLYS) reported unrecognized tax benefits of $6.49M in Q4 2025.
How has Mineralys Therapeutics, Inc.'s unrecognized tax benefits changed year-over-year?
Mineralys Therapeutics, Inc.'s unrecognized tax benefits increased by 44.0% year-over-year, from $4.51M to $6.49M.
What is the long-term trend for Mineralys Therapeutics, Inc.'s unrecognized tax benefits?
Over 4 years (2021 to 2025), Mineralys Therapeutics, Inc.'s unrecognized tax benefits has grown at a 172.3% compound annual growth rate (CAGR), from $118K to $6.49M.